Nasdaq:US$17.52 (+0.08) | HKEX:HK$27.60 (+0.68) | AIM:£2.54 (+0.07)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 27 Sep 2015

ESMO 2015: Phase II trial of fruquintinib in metastatic colorectal cancer

1 items
View PDF